CDK4 and neoplasm: However, in addition to this, continual CDK4/6 inhibitor dosing could also induce genotoxic damage if this dose causes cell cycle delays instead of a complete G1 arrest, as we observed in a range of tumour types that cannot be fully arrested by palbociclib (Fig 7).